key: cord-0704466-h7fqtcng authors: Alam, Sadia; Sadiqi, Shahida; Sabir, Maimoona; Nisa, Sobia; Ahmad, Sajjad; Abbasi, Sumra Wajid title: Bacillus species; a potential source of anti-SARS-CoV-2 main protease inhibitors date: 2021-01-15 journal: Journal of biomolecular structure & dynamics DOI: 10.1080/07391102.2021.1873188 sha: 7e1a03b827cb2643f3156bd5e624e0acdc098f64 doc_id: 704466 cord_uid: h7fqtcng The COVID-19 being a preconized global pandemic by the World Health Organization needs persuasive immediate research for possible medications. The present study was carried out with a specific aim to computationally evaluate and identify compounds derived from Bacillus species as the plausible inhibitors against 3-chymotrypsin-like main protease (3CLpro) or main protease (M(Pro)), which is a key enzyme in the life-cycle of coronavirus. The compounds were isolated from the crude extracts of Bacillus species. Among the isolated compounds, novel inhibitory leads were identified using in silico techniques. Molecular docking revealed that stigmasterol (-8.3 kcal/mol), chondrillasterol (-7.9 kcal/mol) and hexadecnoic acid (-6.9 kcal/mol)) among others bind in the substrate-binding pocket and also interacted with the catalytic dyad of the 3-CLpro. Further evaluation using 50 ns molecular dynamic simulation and MMPB-GBSA indicated that among the top three docking hits, hexadecanoic acid was found to be the most promising anti-COVID-19 lead against the main protease. Hexadecanoic acid might serve as a potent anti-SARS-CoV-2 compound to combat COVID-19, however, in vitro and in vivo validation and optimization is needed. Communicated by Ramaswamy H. Sarma A novel strain of the coronavirus SARS-CoV-2 was detected on December 29, 2019, in Wuhan city of China, which affects the lower respiratory tract and causes severe acute respiratory syndrome in patients (Adhikari et al., 2020) . WHO declares coronavirus infection (COVID-19) as a public health emergency of international concern, affecting millions of people, and it is spreading worldwide with a mortality rate of approximately 3% (https://www.who.int/emergencies/diseases/novel-coronavirus-2019). COVID-19 has clinically significant characteristics that cause certain disease conditions such as; pneumonia, fever, difficulty in breathing, infection of the lung. Coronaviruses (CoVs) are enveloped, single-stranded RNA viruses that infect large number of vertebrates. CoVs species are zoonotic and transmitted to humans via droplets of different sizes. A total of six coronavirus species are responsible for inducing clinical complications in humans. Four out of six named as; 229E, OC43, NL63, and HKU1 are most common and generally cause common cold in immune-compromised individuals . The remaining two strains named; Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV) are zoonotic and cause severe clinical complications (Cui et al., 2019) . The 3 C-like protease (3CLpro) along with papain-like protease(s) is the main protease enzyme that is significant for the processing of the viral polyproteins (John et al., 2015) . This role of 3CLpro in duplication of the virus makes it an ideal drug target for the identification and designing of potent anti-SARS-CoV-2 inhibitors. Microorganisms are the most abundant living entity on the earth's surface, which interacts with other organisms that flourish in the biosphere. Both of them create an interactive network that constitutes the basis for life on the planet Earth (Cani & Knauf, 2016; Nicholson et al., 2012; O'Mahony et al., 2015) . Bioactive compounds produced by microorganisms are quite significant for developing novel drugs and diverse substances with various biological activities, including antifungal, antibacterial, anti-inflammatory, anticancer, and antiviral. These new substances and novel drugs are costeffective and highly efficient (Lavecchia & Di Giovanni, 2013; Tripathi & Misra, 2017) . Bacteria of the Bacillus genus are gram-positive, rod-shaped, and can form endospores. Due to their diversity in physiological properties, they have the ability to produced plethora of antimicrobial compounds (AMCs) (at least 4-5% of its genome) to favour their ubiquitous distribution in soil and environment (Caulier et al., 2019) . Keeping this in mind, the current study aimed to investigate the antiviral efficacy of crude extract compounds produced by soil Bacillus species as 3CLpro-inhibitors. This study involves molecular docking and molecular dynamics (MD) simulation analysis to evaluate the potential of secondary metabolites identified through GC-MS in extracts of Bacillus species as potential drugs against COVID-19 and as significant standardization markers. Soil samples were collected from different regions of Khyber Pakhtunkhwa (Haripur, Swat, and Charsada). By using sterile polythene bags approximately 4 g of soil samples were collected. All the samples were shifted to the lab under sterile conditions for further processing as previously described by McPherson et al. (2018) . From each sample, one gram of soil was suspended in sterile distilled water (9 ml volume) and strongly shaken for 2-3 min for dissolution. Sterile normal saline (0.85%) was used for serial dilution of soil suspension. Then serial dilutions up to 10 À6 were prepared using sterile normal saline. From each dilution, an aliquot of 0.1 ml was taken and lawned on Petri plates containing isolation media. Nutrient agar, GYMS medium, and Tryptic Soy Broth with an additional 0.5% yeast extract (modified Tryptic Soy Broth, pH 7.4 at 37 C under shaking condition) used for the isolation of bacterial colonies from soil samples. The plates were incubated at 30 C and monitored after 24 h before the selection of the bacterial colonies (McPherson et al., 2018) . Plates were then examined and suspected colonies were Gram staining stained. The rod-shaped, spore-forming grampositive bacilli were selected for additional identification tests. Consecutive identification tests were done via sugar fermentation, starch hydrolysis, motility, Indole production, Voges-Proskauer VP, nitrate reduction, catalase, and gas production. Selected bacterial isolates were inoculated in Erlenmeyer flask of Nutrient broth followed by incubation for 3 to 4 days. Afterward, the fermentation flask was incubated in a rotary shaker at 110 rpm for 7 days. Secondary metabolites were excreted, the broth culture was filtered and added with solvent ethyl acetate. The solvent layer was separated, stored in a sterile flask to allow evaporation of ethyl acetate extract using a rotary evaporator. Before further use, the extract was stored at 4-5 C. Crude extract of each sample was used to investigate their chemical composition by using GC-MS, which has high sensitivity and specificity as previously described by Begum et al. (2016) . GC-MS was performed in a Thermo Scientific GC Focus Series DSQ. Helium gas was used as carrier keeping the flow rate constant (1 ml/min) with 1ul injection volume. A 22-min run was accomplished and injector temperature was maintained at 250 C, the oven temperature was set at110 C, with an increase of 10 C/min to 200 C, after that 5 C/ min to 280 C, closing with 9 min isothermal at a temperature of 280 C. Peaks responding to the compounds were eluted from the GC column and recorded along with retention time. The data obtained were compared with mass spectra, and the database was sought for homologous compounds of the same molecular mass and retention time. Biological activities of the reported natural compounds were also studied, and comparability was made to correlate the activities of bacterial extracts with their components. For this study, compounds with a strong manifestation of biological activities were selected. Chemical structures of selected compounds were drawn using Chem Office 2004 (Li et al., 2004) . After that, the structures were converted into. mol2 format using Chem3D Ultra. UCSF Chimera 1.14 was used for structural geometry optimization of the compounds (Pettersen et al., 2004) . The three dimensional (3 D) structure of the 3CLpro (PDB ID:6LU7) was retrieved from the protein data bank (https://www.rcsb.org/structure/6LU7). Crystallographic water molecules along with co-crystallized have been removed from the PDB file of the target. The docking study was accomplished by using Autodock/ vina at the active site of 3CLpro to explain the mechanism of inhibition of selected compounds at the molecular level (Trott & Olson, 2010) . Preparatory steps were followed as mentioned; addition of polar hydrogens to the protein structure, checking for missing residues, generation of pdbqt files for both ligands and receptor along with the setting of grid box around the active site was accomplished by using GUI program of Auto Dock Tool (Morris et al., 2009) . The grid size dimensions were allowed as 40 Â 40 Â 40 along X, Y, and Z axes with 0.375 Å spacing. The pdbqt files with grid box properties were recorded into a configuration file. During the docking run, both protein and ligand were treated as rigid entities. In positional RMSD, the results of less than 1.0 Å were clustered and were characterized in the most conducive free energy of binding. For further analysis, a low binding affinity pose has been extracted and aligned with the protein. The docking protocol was validated by docking cocrystallized N inhibitor at the active site of 3CLpro using the same parameters described above and the predicted pose was found the same as reported in the crystal structure thus validating the docking procedure. Dynamics of selected docking complexes, 50 ns MD simulation was carried out using AMBER 18 software (Case et al., 2010) using a similar protocol as defined in our previous studies (Abbasi et al., 2016; Wahedi et al., 2020) . The simulation trajectories were further assessed by analyzing various physical properties: Root Mean Square Deviation (RMSD), Root Mean Square Fluctuation (RMSF), and Gyration Radius (Rg). Additionally, hydrogen bond analysis using VMD (https://www.ks.uiuc.edu/Research/vmd/) was also performed. The free energy of the binding of the docked complex was estimated using the methodology reported by Abro and Azam (2016) . The results of GC-MS evaluation indicate the presence of several compounds in crude extracts of Bacillus species. The most important highest components exhibited in the crude extract analyzed with the help of GC-MS are documented in Tables 1-3. The crude extracts of Bacillus species show the presence of bioactive compounds and these compounds are alkaloid, steroid, saturated fatty acid, and lipid in nature. Different compounds have been found to possess a wide range of activities. The compounds are known to have anti-bacterial, anti-fungal, anti-viral, anti-ulcer, anti-cancer, anti-oxidant, anti-arthritic, anti-asthma, anti-psychotic, nematocidal, and pesticide activity. A molecular docking study was conducted to better understand the mechanism of binding of compounds to SARS-CoV-2 3CLpro at the molecular level. To predict their binding affinities and modes, interactions between SARS-CoV-2 3CLpro and compounds were analyzed. Top-ranked compounds, based on binding affinities (chondrillasterol À7.9 kcal/mol, cholestan À7.8 kcal/mol, trifluoroacetic acid À7.7 kcal/mol, octadeccenoic-acid À9.9 kcal/mol, stigmasterol À8.3 kcal/mol, 9 octsdecenoic-acid À9.7 kcal/mol, and hexadecnoic acid À6.9 kcal/mol) were selected for further in silico analysis. Visual exploration of the binding patterns of the aforesaid compounds identified three bioactive compounds: stigmasterol (-8.3 kcal/mol), chondrillasterol (-7.9 kcal/mol) and hexadecnoic acid (-6.9 kcal/mol)) that are hypothesized and predicted to fit inside the substrate-binding pocket, and also interact with the catalytic dyad comprising of His41 and Cys145 (Figure 1 ) (Jin et al., 2020; Macchiagodena et al., 2020) . Stigmasterol is produced by different species . of Bacillus and have anti-inflammatory activity (Zeb et al., 2017) . The molecular interaction studies of stigmasterol showed that it was not only able to bind to the 3CLpro's catalytic dyad (HIS41-CYS145) but also exhibit the affinity for the residues of substrate binding site: MET49, PHE140, LEU141, ASN142, GLY143, SER144, MET165, GLU166, LEU167, PRO168 and GLN 189 ( Figure 2) . The 3 D analysis of the docked complex using VMD revealed that catalytic dyad HIS41, CYS145 along with other important residues (SER144, GLY143, and LEU141) played a vital role in stabilizing the docked conformation by making eight hydrogen bonds of 2.44 Å, 3.39 Å, 2.73 Å, 2.69 Å, 3.84 Å, 3.25 Å 3.78 Å and 3.87 Å, respectively with the electronegative as well as hydrogen atoms of stigmasterol. Additionally, the carbonyl atoms of ligand and carbon atoms of important interacting residues of 3CLpro, namely: GLU166, MET165, GLN189, THR190, and ALA191 produced a network of hydrophobic interactions (Table 4 and Figure 3a ). Two dimensional (2 D) interactions map generated using complex using Discovery studio highlighted additional interactions not evident from the results viewed using VMD. As shown in Figure 3b , HIS41, MET49, LEU141, ASN142, GLY143, HIS164, MET165, and GLU166 were involved in van der Waals interaction. An alkyl interaction with PRO168 and two pi-alkyl interaction with CYS145 and HIS163 were also observed. Chondrillasterol, which is a lipid sterol and has anti-proliferative and antimicrobial properties (Mozirandi et al., 2019) , also binds with the key residues of the active site namely: HIS41, MET49, PRO52, TYR54, PHE140, LEU141, ASN142, CYS145, HIS164, MET165, GLU166, ASP187, ARG188, GLN189 ( Figure 4) . ARG188, ASP187, and MET49 were involved in the hydrogen bond interactions. ARG188 was also involved in an ionic interaction of 3.35 Å. LEU141, GLU166, MET165, GLN189, and HIS41 were involved in the hydrophobic contacts (Table 4 and Figure 5a ). No notable interactions with CYS145 have been observed within 4 Å. 2 D interaction map illustrated that ASN142, GLU166, GLN189, ARG188, ASP187, MET49, and HIS 164 were involved in van der Waals interaction ( Figure 5b) . A conventional hydrogen bond between TYR54 and the oxygen atom of the compound was observed. A pi-alkyl interaction with the residue of the catalytic dyad, HIS41, and alkyl interactions with LEU141 and MET 165 were also observed. Like the aforesaid two compounds, hexadecanoic acid also exhibited an affinity for the residue of the catalytic dyad and interacting residues of the active site as shown in Figure 6 . The 3 D interactions map generated for hexadecnoic acid-3CLpro docked complex revealed that hexadecnoic acid occupied the substrate-binding site through a network of hydrogen bond interactions between the hydrogen atoms and the electronegative atoms of the interacting residues (GLY143, SER144, HIS163, and LEU141) and the studied compound. It was observed that the sulfur atom of catalytic site CYS145 along with the amine group also participated in the formation of two hydrogen bonds (CYS145: SG--UNK: H 2.97 Å, CYS145: HN--UNK: O 2.85 Å). Anionic interaction between the nitrogen atom of CYS145 and the oxygen atom of a small compound at a distance of 2.26 Å was also observed. HIS163 and SER144 also interacted with Hexadecnoic-acid through ionic interactions. ALA191, THR190, and GLN 189 were involved in the hydrophobic contacts (Table 4 and Figure 7a ). The van der Waals interactions, conventional hydrogen bond interaction, as well as alkyl interactions, were observed using discovery studio (Figure 7b ). The aforementioned screened compounds not only exhibited good binding affinities but also showed hydrogen bond interactions with the catalytic dyad and other important residues of pocket, recommending these compounds for further atomic level optimization through molecular dynamics simulation. We performed MD simulations to validate the docking findings and to further analyze the binding pattern and stability of potential compounds. Also, the docked complexes were rescored using MMPBSA to verify the docking results and to rank the binding affinities accordingly. Based on the results of MMPBSA, it was concluded that hexadecnoic acid-3CLpro is the most stable complex for further study compared to stigmasterol-3CLpro and chondrillasterol-3CLpro docked complexes with better docking affinities. The estimated average potential energy for the hexadecnoic acid-3CLpro complex after 50 ns was À144302 kcal/mol which revealed the complex's stability. The RMSD plot showed that protein attains the equilibrium after 1 ns and remains stable till 50 ns with few minor deviations and an average RMSD value of 1.6 Å (Figure 8a) . Snapshots extracted at different intervals revealed that around 10 ns the compound moved a little bit from the initial docked conformation, binds into the substrate-binding pocket, and catalytic dyad (HIS41, CYS145) and stays there till the entire simulation run. Visualization through the using Discovery Studio showed that both the residues of the catalytic dyad (HIS41 and CYS145) along with MET160 were involved in pi-alkyl and alkyl interactions. THR190 and GLN198 were involved in a conventional hydrogen bond as well as a carbon-hydrogen bond, respectively. Thirteen residues, including the residues of substrate binding site (THR25, THR26, LEU27, ASN28, TYR54, ASN119, ASN142, GLY143, SER144, HIE164, ASP187, GLN189, and ALA191) were interacting using van der Waals interactions to form a stable complex (Figure 9a and b) . Most of these residues have been reported as crucial because of their involvement in the formation of the substrate-binding pocket (Jin et al., 2020) . The plot for the radius of gyration also revealed that the system attained compactness and stability (22.2 Å) and the results achieved are consistent with the results of RMSD stated herein (Figure 8b ). The RMSF analysis was conducted to Illustrating the active site residues of best-docked conformation selected for stigmasterol-3CLpro, visualized using Chimera. Residues of substrate binding sites are shown in black color whereas catalytic dyad residues are shown in reddish-orange color. explore the per residue fluctuations of the system. The binding of Hexadecnoic-Acid has been shown to make proteins less flexible, especially in regions containing catalytic dyad and interacting residues of pocket. The average RMSF for the system was 1.02 Å, especially for HIS41 and CYS145 it was estimated as 0.50 Å and 0.71 Å (Figure 8c ). For the residue of domain III, especially residues 300-303, a higher fluctuation of approximately 4.66 Å was observed. The possible reason for this higher fluctuation could be the involvement of domain III in the formation of a homodimer. RMSD plot for ligand showed few deviations with an average RMSD of 2.05 Å (Figure 10a ). When snapshots for the ligand were analyzed, it was observed that the deviations in the RMSD plot were because of the flexibility of the carboxyl group. As shown in Figure 10 b at 10 th , 15 th, and 45 th ns this group showed a major deviation from the initial conformation. The chain of carbon atoms remained stable throughout the simulation run playing an anchoring role in the binding of the compound to the protein. This finding could be significant for the future design of potent compounds that use this compound as the lead. The compound's flexible moiety may be substituted by another group that may limit its movement and the ability to increase the potency that optimally inhibits the 3CLpro. Over the entire simulation run, the complex remains stable. Hydrogen bonds play a vital role in maintaining the stability of the docked complex, so the hydrogen bond calculation significantly highlights the stability of the studied complex (Gerlt et al., 1997) . To gain insight into the stable complex, it is therefore essential to assess the number of hydrogen bonds between protein-ligand interacting regions. The hydrogen bond plot for hexadecnoic acid-3CLpro docked complex generated by VMD is shown in Figure 11 . The figure shows that, on average, two hydrogen bonds were observed between the interactive residues and Hexadecnoic-Acid, during the entire MD spam. The results are consistent with the MD predictions. Free binding energies were calculated using the MMPBSA and MMGBSA methods for 100 snapshots of the last 10 ns trajectories. Very strong protein-compound interactions have been demonstrated for both approaches. The entropy has been omitted because it cannot be measured in certain situations due to convergence issues. In both techniques, the contribution of gas-phase energy to the overall net energy of the system is considerably high as compared to the net solvation energy of the system, which shows complex stability primarily due to the receptor's best confirmation with respect to the ligand. For both cases, net gas phase energy was À38.29 kcal/mol. Van der Waals interactions (À34.90 kcal/mol) have also contributed favorably in addition to the minor contribution from electrostatic energy towards the gas-phase energy. The total binding free energy calculated for the complex using MMPBSA and MMGBSA methods was À22.42 kcal/mol and À28.67 kcal/mol receptively, shown in Table 5 . The accelerated increase of COVID-19 infections and prevailing disease severity compels an urgent need of scheming remedial measures through small compound or peptide drugs to cure the COVID-19. In this regard, using in silico approaches, among the nine bacterial compounds extracted from the soil, we identified Hexadecnoic-Acid as a plausible inhibitor against COVID-19 Main Proteases. Hexadecanoic acid is an aliphatic long-chain fatty acid that has shown potential antibacterial and antifungal activity (Begum et al., 2016) . It is anticipated that the findings of the current study, after in vivo and in vitro testing, may prove significant for developing novel antimicrobial therapeutic agents against COVID-19. ARG188:N-UNK:O 3.35 LEU141:CD2-UNK:C3.98 LEU141:CB-UNK:C 3.93 GLU166:CD-UNK:C3.96 GLU166:CB-UNK:C3.60 GLU166:CB-UNK:C3.58 MET165:CA-UNK:C3.95 MET165:CB-UNK:C3.75 MET165:CB-UNK:C3.56 MET165:CB-UNK:C3.53 MET165:CB-UNK:C3 Hexadecanoic acid À6.9 GLY143:HN-UNK:O 3.28 GLY143N-UNK:H 3.68 SER144:HN-UNK:O 2.60 HIS163:HE2-UNK:O 2.02 HIS163:HE2-UNK:O 3.66 CYS145:SG-UNK:H 2.97 Docked poses of Stigmasterol with 3CLpro main protease. (a) 3 D representation of interactions using VMD, protein is represented in dotes style whereas compound is in CPK style. (b) 2 D representation of key interactions using Discovery studio Interaction mechanisms of a melatonergic inhibitor in the melatonin synthesis pathway Binding free energy based analysis of arsenic (þ 3 oxidation state) methyltransferase with S-adenosylmethionine Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review GC-MS analysis of bio-active molecules derived from paracoccus pantotrophus FMR19 and the antimicrobial activity against bacterial pathogens and MDROs How gut microbes talk to organs: The role of endocrine and nervous routes AMBER 12 Overview of the antimicrobial compounds produced by members of the Bacillus subtilis group Origin and evolution of pathogenic coronaviruses Understanding enzymic catalysis: The importance of short, strong hydrogen bonds Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4-The likely reservoir Virtual screening strategies in drug discovery: A critical review Personal experience with four kinds of chemical structure drawing software: Review on ChemDraw, ChemWindow, ISIS/Draw, and ChemSketch Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals Inhibition of the main protease 3cl-pro of the coronavirus disease 19 via structurebased ligand design and molecular modeling Isolation and analysis of microbial communities in soil, rhizosphere, and roots in perennial grass experiments AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility Evaluation of antimicrobial activity of chondrillasterol isolated from Vernonia adoensis (Asteraceae) Host-gut microbiota metabolic interactions Serotonin, tryptophan metabolism and the brain-gut-microbiome axis UCSF Chimera-a visualization system for exploratory research and analysis Molecular docking: A structure-based drug designing approach The authors are highly grateful to the Higher Education Commission (HEC) Pakistan for financial assistance. We acknowledge the National University of Medical Sciences and The University of Haripur, Haripur, KPK for providing laboratory facilities. All authors would like to acknowledge the participants who contributed to this research and the university staff and administration for their cooperation. The authors would also like to acknowledge unwavering moral and emotional support from family and friends. No potential conflict of interest was reported by the authors. This work was supported by Higher Education Commission of Pakistan.